Practicalities of Impracticability: An Interim Review of Randomized Controlled Trials

J Empir Res Hum Res Ethics. 2022 Jul;17(3):329-345. doi: 10.1177/15562646221092663. Epub 2022 Apr 19.

Abstract

Impracticability is an ethical standard for waiver of informed consent in research. We examine how well the criterion of impracticability appears to have been fulfilled in a set of 36 completed randomized controlled trials (RCTs) that secured consent from some subjects or LARs and employed waivers to enroll others. These trials were identified among 155 RCTs using waivers of consent in a convenience sample drawn from 7 systematic reviews. Recruitment data were available for 19 of the 36 trials, revealing an average of 41.6% of subjects (range 0.2-98.7%, 95% CI: 24.8-58.4%) were enrolled without consent. Six trials enrolled less than 10% of subjects without consent and an overlapping set of 9 trials sought consent from all subjects or LARs at some sites while waiving consent at other sites. We question whether these trials were practicable without waivers and identify issues for consideration by investigators and ethics review boards.

Keywords: EFIC; deferred consent; delayed consent; exception from informed consent; impracticability; waiver of informed consent.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Ethics, Research*
  • Humans
  • Informed Consent*
  • Randomized Controlled Trials as Topic
  • Research Design
  • Research Personnel